001
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Cedar Court Pkwy, St Albans, Hertfords...Phone Number
+44 1727857600Website
www.001ltd.co.ukRevenue
<$5 MillionIndustry
About 001
001 Org Chart
Is 001 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if 001 has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at 001
001, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when 001 launches new products
Funding: Get notified immidiatlly once 001 has new funding data
Earning: See what the market has to say on 001 recently announced quarterly report
Check out if 001 is spiking on competitors!
Click to see if 001 had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined 001 as Masked Content
Find 2 more new buyers
Compare Similar Companies to 001
Compare insights from companies similar to 001, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
001 is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
001 is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about 001.
001 Tech Stack
A closer look at the technologies used by 001
001 News & Media
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026
Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients SEONGNAM and SEOUL, South Korea,...Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026
Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients SEONGNAM and SEOUL, South Korea, June 15, 2026 /PRNewswire/ -- Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the Phase 1/2a interim clinical results for 'RZ-001 (TaspitimageCrescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
ASCEND Phase 1/2 global clinical trial evaluating CR-001 in multiple solid tumor types, including NSCLC, gastrointestinal and gynecological cancers in first-line and previously treated patientsRestore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy
Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key May 2026 meetings: Eyecelerator and Retinal Therapeutics Innovation Summit. No dose-limiting toxicities (DLTs) or drug-related serious...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 001
001Ltd is an independent commercial utility consultancy with over 20 years of experience, specializing in helping businesses save time and money on their utility expenses. They offer a range of services including business energy procurement, historic energy audits, and energy consumption analysis. Their clients span various sectors such as leisure,... Read More